The WACC of Livewire Ergogenics Inc (LVVV) is 3.6%.
Range | Selected | |
Cost of equity | 3.6% - 6.9% | 5.25% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 4.0% - 4.5% | 4.25% |
WACC | 3.1% - 4.2% | 3.6% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | -0.06 | 0.36 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 3.6% | 6.9% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 3.05 | 3.05 |
Cost of debt | 4.0% | 4.5% |
After-tax WACC | 3.1% | 4.2% |
Selected WACC | 3.6% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
LVVV | Livewire Ergogenics Inc | 3.05 | 2.8 | 0.87 |
EVE.V | Eve & Co Inc | 5.29 | 0.89 | 0.18 |
GBLP | Global Pharmatech Inc | 0.03 | 0.17 | 0.17 |
GENX.V | GenixPharmaceucticals Corporation | 0.51 | -0.52 | -0.38 |
KGKG | Kona Gold Beverage Inc | 1209.24 | 1.42 | 0 |
LQWC | Lifequest World Corp | 3.22 | -0.76 | -0.23 |
NUVM | NuVim Inc | 0.48 | -0.5 | -0.37 |
NWYU | New You Inc | 67.79 | 0.99 | 0.02 |
SXTC | China SXT Pharmaceuticals Inc | 0.06 | 0.37 | 0.35 |
VPI.V | Vitality Products Inc | 0 | -0.51 | -0.51 |
Low | High | |
Unlevered beta | -0.09 | 0.08 |
Relevered beta | -0.58 | 0.04 |
Adjusted relevered beta | -0.06 | 0.36 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for LVVV:
cost_of_equity (5.25%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (-0.06) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.